A SECRET WEAPON FOR AZELAPRAG AMGEN

In December, BioAge announced a multi-calendar year investigate collaboration with Novartis to detect and validate novel therapeutic targets for the intersection of growing old biology and work out, combining BioAge's longitudinal human growing old datasets with Novartis skills in exercising biology.If this doesn’t occur to get a drug and several